| Structural basis for mismatch surveillance by CRISPR–Cas9 JPK Bravo, MS Liu, GN Hibshman, TL Dangerfield, K Jung, RS McCool, ... Nature 603 (7900), 343-347, 2022 | 301 | 2022 |
| Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA MS Liu, S Gong, HH Yu, K Jung, KA Johnson, DW Taylor Nature communications 11 (1), 3576, 2020 | 115 | 2020 |
| Kinetic characterization of Cas9 enzymes MS Liu, S Gong, HH Yu, DW Taylor, KA Johnson Methods in enzymology 616, 289-311, 2019 | 19 | 2019 |
| Structural mechanism for the fidelity modulation of DNA polymerase λ MS Liu, HY Tsai, XX Liu, MC Ho, WJ Wu, MD Tsai Journal of the American Chemical Society 138 (7), 2389-2398, 2016 | 17 | 2016 |
| Thermococcus sp. 9°N DNA polymerase exhibits 3′-esterase activity that can be harnessed for DNA sequencing SW LinWu, YH Tu, TY Tsai, M Maestre-Reyna, MS Liu, WJ Wu, JY Huang, ... Communications Biology 2 (1), 224, 2019 | 10 | 2019 |
| Structural Analysis of Glycine Sarcosine N-methyltransferase from Methanohalophilus portucalensis Reveals Mechanistic Insights into the Regulation of … YR Lee, TS Lin, SJ Lai, MS Liu, MC Lai, NL Chan Scientific reports 6 (1), 38071, 2016 | 10 | 2016 |
| Basis for discrimination by engineered CRISPR/Cas9 enzymes MS Liu, S Gong, HH Yu, K Jung, KA Johnson, DW Taylor BioRxiv, 630509, 2019 | 5 | 2019 |
| LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers LCM Martires, LG Ahronian, CB Pratt, NM Das, X Zhang, DA Whittington, ... Molecular Cancer Therapeutics 24 (4), 618-627, 2025 | 4 | 2025 |
| A duplexed high-throughput mass spectrometry assay for bifunctional POLB polymerase and lyase activity ZA Gurard-Levin, B McMillan, DA Whittington, B Doyon, MD Scholle, ... SLAS technology 29 (5), 100173, 2024 | 4 | 2024 |
| POLB knockout is synthetic lethal with PARP inhibition leading to complete and durable responses in BRCA-mutant tumor xenografts M Bandi, K Lazarides, J Engel, T Feng, M Meseonznik, A Choi, Y Yu, ... Manuscript in Preparations. Published online, 2024 | 2 | 2024 |
| Abstract C104: Hit finding and assay enablement for MGAT1, a novel glycosyl transferase involved in cancer cell immune evasion KB Handing, MS Liu, DA Whittington, S Sun, R Salerno, WD Mallender, ... Molecular Cancer Therapeutics 24 (10_Supplement), C104-C104, 2025 | | 2025 |
| Cas9 variants with improved specificity DW Taylor, KA Johnson, JPK BRAVO, MS LIU, T DANGERFIELD, ... US Patent App. 18/691,246, 2025 | | 2025 |
| Cas9 variants with improved specificity DW Taylor, KA Johnson, JPK BRAVO, T DANGERFIELD, GN HIBSHMAN | | 2023 |
| Structural basis for mismatch surveillance by CRISPR-Cas9 (vol 603, pg 343, 2022) JPK Bravo, MS Liu, GN Hibshman, TL Dangerfield, K Jung, RS McCool, ... NATURE 604 (7904), E10-E10, 2022 | | 2022 |
| Kinetic Basis for Improved Specificity of CRISPR/Cas9 High Fidelity Variants MS Liu, S Gong, HH Yu, DW Taylor, KA Johnson The FASEB Journal 33 (S1), 620.4-620.4, 2019 | | 2019 |
| DNA 聚合酶 λ 結構機制探討之忠實度調節 劉沐森 國立臺灣大學生化科學研究所學位論文, 1-111, 2016 | | 2016 |
| SLAS Technology ZA Gurard-Levin, B McMillan, DA Whittington, B Doyon, MD Scholle, ... | | |
Kenneth A JohnsonProfesor of Biochemistry, University of Texas, Penn State University, University of ChicagoVerified email at mail.utexas.edu
